Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation

Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation

Autologous hematopoietic stem cell transplantation (AHSCT) is an increasingly used curative treatment for some solid tumors in children. Instead of allogeneic transplantation, the risk of developing graft-versus-host disease (GvHD) is much lower after AHSCT. Although the clinical findings of auto-GV...

Full description

Bibliographic Details
Main Authors: Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, Ahmet Koç
Format: Article
Language:English
Published: Galenos Yayinevi 2022-06-01
Series:Journal of Pediatric Research
Subjects:
autologous stem cell transplantation
children
graft versus host disease
ruxolitinib
steroid-resistant
Online Access: http://jpedres.org/archives/archive-detail/article-preview/successful-treatment-of-refractory-graft-versus-ho/52013

Internet

http://jpedres.org/archives/archive-detail/article-preview/successful-treatment-of-refractory-graft-versus-ho/52013

Similar Items